Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial.
暂无分享,去创建一个
J. Gohagan | R. Hayes | P. Hartge | R. Hoover | R. Ziegler | J. Weissfeld | D. Reding | A. Subar | N. Caporaso | W. Kopp | N. Rothman | C. Johnson | N. Bhat | C. Palace | R. Ziegler | C. C. Johnson | N. E. Caporaso | Richard B. Hayes | Robert N. Hoover | William Kopp | Narayan Bhat | Nathaniel Rothman | Regina G. Ziegler | Cindy Palace | R. G. Ziegler
[1] J. Gohagan,et al. Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. , 2000, Controlled clinical trials.
[2] J. Gohagan,et al. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. , 2000, Controlled clinical trials.
[3] L. Le Marchand,et al. A simple mouthwash method for obtaining genomic DNA in molecular epidemiological studies. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[4] Nathaniel Rothman,et al. Application of Biomarkers in Cancer Epidemiology , 1997 .
[5] N. Breslow,et al. Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.